N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis

Boon, Kathy; Caron, Huib N.; van Asperen, Ronald; Valentijn, Linda; Hermus, Marie-Christine; van Sluis, Peter; Roobeek, Ilja; Weis, Isabel; Voûte, P. A.; Schwab, Manfred; Versteeg, Rogier
March 2001
EMBO Journal;3/15/2001, Vol. 20 Issue 6, p1383
Academic Journal
The myc oncogenes are frequently activated in human tumors, but there is no comprehensive insight into the target genes and downstream cellular pathways of these transcription factors. We applied serial analysis of gene expression (SAGE) to identify targets of N-myc in neuroblastomas. Analysis of 42 000 mRNA transcript tags in SAGE libraries of N-myc- transfected and control neuroblastoma cells revealed 114 up-regulated genes. The majority of these genes have a role in ribosome assembly and activity. Northern blot analysis confirmed up-regulation of all tested transcripts. Induction was complete within 4 h after N-myc expression. The large majority of the ribosomal proteins were induced, as well as genes controlling rRNA maturation. Cellular rRNA content was 45% induced. SAGE libraries and northern blot analysis confirmed up-regulation of many of these genes in N-myc-amplified neuroblastomas. As N-myc can functionally replace c-myc, we analyzed whether N-myc targets were induced by c-myc as well. Approximately 40% of these N-myc targets were up-regulated in a c-myc-transfected melanoma cell line. These data suggest that myc genes function as major regulators of the protein synthesis machinery.


Related Articles

  • MYC as a regulator of ribosome biogenesis and protein synthesis. van Riggelen, Jan; Yetil, Alper; Felsher, Dean W. // Nature Reviews Cancer;Apr2010, Vol. 10 Issue 4, p301 

    MYC regulates the transcription of thousands of genes required to coordinate a range of cellular processes, including those essential for proliferation, growth, differentiation, apoptosis and self-renewal. Recently, MYC has also been shown to serve as a direct regulator of ribosome biogenesis....

  • Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Barna, Maria; Pusic, Aya; Zollo, Ornella; Costa, Maria; Kondrashov, Nadya; Rego, Eduardo; Rao, Pulivarthi H.; Ruggero, Davide // Nature;12/18/2008-12/25/2008, Vol. 456 Issue 7224, p971 

    The Myc oncogene regulates the expression of several components of the protein synthetic machinery, including ribosomal proteins, initiation factors of translation, RNA polymerase III and ribosomal DNA. Whether and how increasing the cellular protein synthesis capacity affects the multistep...

  • c-myc: more than just a matter of life and death. Pelengaris, Stella; Khan, Mike; Evan, Gerard // Nature Reviews Cancer;Oct2002, Vol. 2 Issue 10, p764 

    Deregulated expression of c-MYC occurs in a broad range of human cancers and is often associated with poor prognosis, indicating a key role for this oncogene in tumour progression. However, as established human tumours often bear multiple genetic lesions, it is difficult to determine whether...

  • A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: A novel mechanism of oncogene de-regulation. Chappell, Stephen A; LeQuesne, John PC; Paulin, Fiona EM; deSchoolmeester, Matthew L; Stoneley, Mark; Soutar, Richard L; Ralston, Stuart H; Helfrich, Miep H; Willis, Anne E // Oncogene;9/7/2000, Vol. 19 Issue 38, p4437 

    The 5′ untranslated region of the proto-oncogene c-myc contains an internal ribosome entry segment (IRES) (Nanbru et al., 1997; Stoneley et al., 1998) and thus c-myc protein synthesis can be initiated by a cap-independent as well as a cap-dependent mechanism (Stoneley et al., 2000). In...

  • Crosstalk between Myc and activating transcription factor 2 (ATF2): Myc prolongs the half-life and induces phosphorylation of ATF2. Miethe, Josef; Schwartz, Claudia; Wottrich, Katja; Wenning, Dorit; Klempnauer, Karl-Heinz // Oncogene;12/6/2001, Vol. 20 Issue 56, p8116 

    Myc is a key regulator of cell growth, differentiation and apoptosis, and affects cell fate decisions by activating as well as by inhibiting the expression of cellular genes. Myc is a member of the basic region–helix–loop–helix–leucine zipper (b-HLH-Zip) class of...

  • Diverse developing mouse lineages exhibit high-level c-Myb expression in immature cells and loss of expression upon differentiation. Ess, Kevin C; Witte, David P; Bascomb, Charles P; Aronow, Bruce J // Oncogene;1/28/99, Vol. 18 Issue 4, p1103 

    The c-myb gene encodes a sequence specific transactivator that is required for fetal hematopoiesis, but its potential role in other tissues is less clear because of the early fetal demise of mice with targeted deletions of the c-myb gene and incomplete of knowledge about c-myb's expression...

  • p27kip1-independent cell cycle regulation by MYC. Berns, Katrien; Martins, Carla; Dannenberg, Jan-Hermen; Berns, Anton; te Riele, Hein; Bernards, René // Oncogene;10/5/2000, Vol. 19 Issue 42, p4822 

    MYC transcription factors are potent stimulators of cell proliferation. It has been suggested that the CDK-inhibitor p27kip1 is a critical G1 phase cell cycle target of c-MYC. We show here that mouse embryo fibroblasts deficient for both p27kip1 and the related p21cip1 are still responsive to...

  • Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Evans, Joanne R.; Mitchell, Sally A.; Spriggs, Keith A.; Ostrowski, Jerzy; Bomsztyk, Karol; Ostarek, Dirk; Willis, Anne E. // Oncogene;9/11/2003, Vol. 22 Issue 39, p6068 

    The 5' untranslated region of the proto-oncogene c-myc contains an internal ribosome entry segment and c-Myc translation can be initiated by cap-independent as well as cap-dependent mechanisms. In contrast to the process of cap-dependent initiation, the trans-acting factor requirements for...

  • From the editors.  // Nature Reviews Cancer;Mar2008, Vol. 8 Issue 3, p157 

    The article introduces a series of articles on MYC oncogenes, started by the journal. The concepts involved in the consideration of how MYC might function as an oncogene may also be relevant to other oncogenes and transcription factors. In first article of this series, Fiona Watt and colleagues...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics